Baxter Reports 2016 Fourth-Quarter and Full-Year Results

Go back to Baxter Reports 2016 Fourth-Quarter and Full-Year Results

Baxter International (BAX) PT Raised to $52 at UBS Following 4Q Report

February 2, 2017 9:46 AM EST

UBS raised its price target on Baxter International (NYSE: BAX) to $52.00 (from $51.00) while maintaining a Neutral rating following the company's 4Q earnings report.

Analyst... More

Baxter International (BAX) PT Raised to $60 at Barclays

February 2, 2017 8:46 AM EST

Barclays raised its price target on Baxter International (NYSE: BAX) to $60.00 (from $57.00) while maintaining a Overweight rating.

... More

Baxter International (BAX) PT Raised to $51.50 at Evercore ISI

February 1, 2017 1:44 PM EST

Evercore ISI raised its price target on Baxter International (NYSE: BAX) to $51.50 (from $50.00) while maintaining a Buy rating.

The firm raised FY 2017 EPS from $2.15 to $2.22, FY 2018 EPS from $2.64 to $2.65 and maintained FY 2019 EPS at $3.15.

Analyst Vijay Kumar commented, "BAX reported a solid finish to the year, beating consensus EPS estimates by double digits and initiating above ST EPS guidance. There were several highlights in the 4Q print, both on the topline and operating metrics that made us incrementally more positive on our turnaround + long term EPS power... More

Baxter (BAX) Tops Q4 EPS by 5c, Q1 EPS Guidance Tops Views

February 1, 2017 7:18 AM EST

Baxter (NYSE: BAX) reported Q4 EPS of $0.57, $0.05 better than the analyst estimate of $0.52. Revenue for the quarter came in at $2.65 billion versus the consensus estimate of $2.64 billion.

GUIDANCE:

Baxter sees FY2017 EPS of $2.10-$2.18, versus the consensus of... More